ID   A172/TMZ
AC   CVCL_D5ZN
DR   Wikidata; Q127378810
RX   PubMed=34036375;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:72564; Temozolomide (TMZ).
CC   Sequence variation: Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=34036375; DOI=10.3892/mmr.2021.12172; PMCID=PMC8170197;
RA   Cao Y.-Q., Chai W.-Y., Wang Y.-G., Tang D., Shao D.-C., Song H.,
RA   Long J.;
RT   "lncRNA TUG1 inhibits the cancer stem cell-like properties of
RT   temozolomide-resistant glioma cells by interacting with EZH2.";
RL   Mol. Med. Rep. 24:533.1-533.10(2021).
//